Abstract:Background and purpose:Researches had indicated that about over 85%of malignant tumors highly express telomerase activity. So telomerase has become one of the important methods in the research field of tumor diagnosis and treatment. Nowadays, several reports about malignant tumor which over expresses hTERT targeting imaging with radionuclide labeled hTERT ASON had been published. In these reports, high quality of pictures can hardly be acquired because of poor anatomical and spacial resolution in nuclear imaging itself. Accordingly, in this study, we developed a method of detecting human telomerase in vivo with magnetic resonance imaging (MRI) and evaluate its feasibility. Methods:Firstly, Uniformly phosphorothioate-modified human telomerase reverse transcriptase antisense oligonucleotide (hTERT ASON) was labeled with Gd3+ through the bifunctional chelator 1, 4, 7, 10-tetraazacyclododecane-N, N’, N’’, N’’’-tetraacetic acid (DOTA) and iv vitro experiments were performed to characterize the antisense probes (for biodistribution and cellular uptake, 99mTc-DOTA-ASON was used in stead of Gd-DOTA-ASON). Then Gd-DOTA-ASON was injected intraperitoneally in pulmonary adenocarcinoma A375 nude mice tumor-bearing BALB/c for in vivo imaging using 7.0 T Micro MRI periodically, tumors and their surrounding tissues were defined as region of interest (ROI) to calculate the signal to noise ratio (SNR) of tumor to muscle using Gd-DTPA as control. Finally, immunohistochemical analysis of telomerase activity of each xenograft was operated 2 days after imaging. Results:The binding efficiency of Gd-DOTA-ASON reached was as high as 65%(63.2±2.4, n=6). And it can maintain 61%in fresh human serum and normal saline at 37℃over 24 h;A375 cells showed an uptake of 8.5%when incubated with 99mTc-DOTA-ASON;In comparing with DOTA-ASON and Gd-DTPA, cells transected with Gd-DOTA-ASON had higher SI when performed MRI with T1WI. The hTERT-expressing xenografts were obviously enhanced by Gd-DOTA-ASON at 0.5-6 h after injection and the SNR can reach 2.37, whereas obvious enhancement only could be found within 2 h after injection of Gd-DTPA. Both labeled and non-labeled antisense probes can suppress the activity of telomerase of A375 cells either in vitro or in vitro. Conclusion:Our research offers proof that Gd-DOTA-ASON can be used as tumor specific targeting MR probe for diagnosing malignant tumors with high expression of telomerase.

Study on in vivo imaging of 99Tcm-hTERT mRNA as antisense molecular probe in breast cancer tumor-bearing nude mice

A novel molecular probe:experimental study in vivo in nude mice bearing tumor

Noninvasive Imaging of Human Telomerase Reverse Transcriptase (htert) Messenger Rna with (99)Mtc-Radiolabeled Antisense Probes in Malignant Tumors

Molecular Imaging and Pharmacokinetics of (99m) Tc-hTERT Antisense Oligonucleotide As a Potential Tumor Imaging Probe.

Study on Pharmacokinetics and Acute Toxicity of Human Telomerase Reverse Transcriptase Antisense Oligonucleotide Molecular Probe

[In-Vivo Tumor Imaging by Radiolabeled RNA Probe Targeting Telomerase].

Preparation and Characterization of 99Tcm-Labeled Antisense Oligonucleotide Targeting hTERT mRNA

Study of Distribution and Antisense Imaging for 99Mtc-Ason-egf in Breast Cancer-Bearing Nude Mouse Models

Noninvasive Visualization Of Rna Delivery With Tc-99m-Radiolabeled Small Interference Rna In Tumor Xenografts

[Uptake Kinetics of Htert Antisense Molecular Probe by Cells and Its Biological Properities].

Two-step radiolabeling human telomerase reverse transcriptase antisense oligonucleotide with 99mTc and in vivo experiment

[In Vivo Imaging of Breast Tumors by a 99mtc Radiolabeled Probe Targeting Microrna-155 in Mice Models].

Magnetic Resonance Tumor Targeting Imaging Using Gadolinium Labeled Human Telomerase Reverse Transcriptase Antisense Probes

Antisense imaging targeting mouse double minute 2 oncogene in prostate cancer xenografts

An Experimental Research of Magnetic Resonance Tumor Targeting Imaging with Gd Labeled Human Telomerase Reverse Transcriptase Antisense Oligonucleotide (Gd-Dota-htert ASON)

[Use of 99Mtc-Survivin Antisense Oligonucleotide in Diagnosis of Hepatocellular Carcinoma: an Experiment with Mice].

In-vitro Inhibitory Activity and In-Vivo Biodistribution of "9"9tc"m Radiolabeled Small Interference RNA

Preparation and Tumor Cell Uptake of Sirna Probe Radiolabeled with Technetium-99m Targeting on Htert Gene

In-vitro Inhibitory Activity and In-vivo Biodistribution of ~(99)Tc~m Radiolabeled Small Interference RNA

Improved Synthesis and Biological Evaluation of Tc-99m Radiolabeled Amo for Mirna Imaging in Tumor Xenografts

Molecular Imaging for PET-CT Reporter Gene in Breast Adenocarcinoma (Hsv1-Tk) of Subcutaneous Xenografts in Living Nude Mice